Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Stem cell-based carriers for RCR vector delivery to glioblastoma

  • Post author:
  • Post published:April 24, 2026
  • Post category:

Modified viruses can be used to infect tumor cells and alter the tumor cell to make anti-tumor proteins. Most researchers use virus that can infect and modify the tumor cell…

Continue ReadingStem cell-based carriers for RCR vector delivery to glioblastoma

Human retinal progenitor cells as candidate therapy for retinitis pigmentosa

  • Post author:
  • Post published:April 24, 2026
  • Post category:

The targeted disease is retinitis pigmentosa (RP), is a severe form of blindness that runs in families. This disease is not overly common, yet represents an attainable near term target…

Continue ReadingHuman retinal progenitor cells as candidate therapy for retinitis pigmentosa

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:April 24, 2026
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

  • Post author:
  • Post published:April 24, 2026
  • Post category:

Leukemia is the most frequent form of cancer in children and teenagers, but is also common in adults. Chemotherapy has vastly improved the outcome of leukemia over the past four…

Continue ReadingDual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication

Epithelial progenitors and the stromal niche as therapeutic targets in lung disease

  • Post author:
  • Post published:April 24, 2026
  • Post category:

Chronic lung disease is an enormous societal and medical problem in California and the nation as a whole, representing the third most likely cause of death. Treatment costs were $389.2…

Continue ReadingEpithelial progenitors and the stromal niche as therapeutic targets in lung disease

Molecular mechanisms involved in adult neural stem cell maintenance

  • Post author:
  • Post published:April 24, 2026
  • Post category:

The adult brain contains a pool of stem cells, termed adult neural stem cells, that could be used for regenerative purposes in diseases that affect the nervous system. The goal…

Continue ReadingMolecular mechanisms involved in adult neural stem cell maintenance

Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

  • Post author:
  • Post published:April 24, 2026
  • Post category:

One in every ten thousand people in the USA have Huntington's Disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingSustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue

  • Post author:
  • Post published:April 24, 2026
  • Post category:

One of the great promises of stem cell research is that it will one day be possible to prepare replacement cells or organs from stem cells such as embryonic stem…

Continue ReadingInactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue

Engineering Embryonic Stem Cell Allografts for Operational Tolerance

  • Post author:
  • Post published:April 24, 2026
  • Post category:

Stem cells, like all transplants not derived from an identical twin, are subject to scrutiny by the immune system and, without medical interventions that suppress the immune system, are usually…

Continue ReadingEngineering Embryonic Stem Cell Allografts for Operational Tolerance

Generation of regulatory T cells by reprogramming

  • Post author:
  • Post published:April 24, 2026
  • Post category:

The goal of our research is to develop efficient methods for making a particular class of immune-system cells known as regulatory T cells (Tregs). Tregs have the potential to be…

Continue ReadingGeneration of regulatory T cells by reprogramming
  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us